Overview / Abstract: |
Target Audience Program Overview Learning Objectives Describe the prevalence of and burden associated with anemia in patients with chronic kidney disease (CKD), particularly those who are hyporesponsive to Erythropoietin Stimulating Agents (ESA) therapy |
Expiration |
Feb 24, 2021 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
.75 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Andrew Howard, MD, FACP |
Sponsors / Supporters / Grant Providers |
Supported by an independent educational grant from AstraZeneca Pharmaceuticals, LP. |
Keywords / Search Terms |
Relias LLC Anemia, CKD, Relias LLC Free CE CME |